Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells

Molecular and Cellular Neuroscience

Volumn 40, Issue 1, 2009, Pages 1-13

  Lorincz, Matthew T ^a   Zawistowski, Virginia A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell differentiation; Embryonic stem cells; Huntington's disease; Neural differentiation; Neural stem cells

Indexed keywords

ADENINE; CYTOSINE; GUANINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE MODEL; EMBRYONIC STEM CELL; HUNTINGTON CHOREA; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBVENTRICULAR ZONE; TRANSCRIPTION REGULATION;

ANIMALS; BIOLOGICAL MARKERS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; HUMANS; HUNTINGTON DISEASE; MICE; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONS; NUCLEAR PROTEINS; STEM CELLS; TRINUCLEOTIDE REPEAT EXPANSION;

ANIMALIA; MURINAE;

EID: 57149122292     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.06.004     Document Type: Article

References (60)

1. Altman J. Are new neurons formed in the brains of adult mammals?. Science 135 (1962) 1127-1128
2. Arvidsson A., Collin T., Kirik D., Kokaia Z., and Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8 (2002) 963-970
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
4. Batista C.M., Kippin T.E., Willaime-Morawek S., Shimabukuro M.K., Akamatsu W., and van der Kooy D. A progressive and cell non-autonomous increase in striatal neural stem cells in the Huntington's disease R6/2 mouse. J. Neurosci. 26 (2006) 10452-10460
5. Borrell-Pages M., Zala D., Humbert S., and Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell. Mol. Life. Sci. 63 (2006) 2642-2660
6. Boutell J.M., Thomas P., Neal J.W., Weston V.J., Duce J., Harper P.S., and Jones A.L. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum. Mol. Genet. 8 (1999) 1647-1655
7. Campbell K., and Gotz M. Radial glia: multi-purpose cells for vertebrate brain development. Trends. Neurosci. 25 (2002) 235-238
8. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., and Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19 (1999) 3248-3257
9. Cattaneo E., Zuccato C., and Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat. Rev. Neurosci. 6 (2005) 919-930
10. Cha J.H. Transcriptional dysregulation in Huntington's disease. Trends. Neurosci. 23 (2000) 387-392
11. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., and Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
12. Cho S.R., Benraiss A., Chmielnicki E., Samdani A., Economides A., and Goldman S.A. Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J. Clin. Invest. 117 (2007) 2889-2902
13. Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., and Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127 (2006) 59-69
14. Curtis M.A., Penney E.B., Pearson A.G., van Roon-Mom W.M., Butterworth N.J., Dragunow M., Connor B., and Faull R.L. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9023-9027
15. Curtis M.A., Penney E.B., Pearson J., Dragunow M., Connor B., and Faull R.L. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience 132 (2005) 777-788
16. Curtis M.A., Waldvogel H.J., Synek B., and Faull R.L. A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain. J. Chem. Neuroanat. 30 (2005) 55-66
17. Eng L.F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8 (1985) 203-214
18. Gerber H.P., Seipel K., Georgiev O., Hofferer M., Hug M., Rusconi S., and Schaffner W. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263 (1994) 808-811
19. Gil J.M., Mohapel P., Araujo I.M., Popovic N., Li J.Y., Brundin P., and Petersen A. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol. Dis. 20 (2005) 744-751
20. Gulisano M., Broccoli V., Pardini C., and Boncinelli E. Emx1 and Emx2 show different patterns of expression during proliferation and differentiation of the developing cerebral cortex in the mouse. Eur. J. Neurosci. 8 (1996) 1037-1050
21. Heng M.Y., Tallaksen-Greene S.J., Detloff P.J., and Albin R.L. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease. J. Neurosci. 27 (2007) 8989-8998
22. Hodges A., Strand A.D., Aragaki A.K., Kuhn A., Sengstag T., Hughes G., Elliston L.A., Hartog C., Goldstein D.R., Thu D., Hollingsworth Z.R., Collin F., Synek B., Holmans P.A., Young A.B., Wexler N.S., Delorenzi M., Kooperberg C., Augood S.J., Faull R.L., Olson J.M., Jones L., and Luthi-Carter R. Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15 (2006) 965-977
23. Hurlbert M.S., Zhou W., Wasmeier C., Kaddis F.G., Hutton J.C., and Freed C.R. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 48 (1999) 649-651
24. Jin K., LaFevre-Bernt M., Sun Y., Chen S., Gafni J., Crippen D., Logvinova A., Ross C.A., Greenberg D.A., and Ellerby L.M. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18189-18194
25. Kegel K.B., Meloni A.R., Yi Y., Kim Y.J., Doyle E., Cuiffo B.G., Sapp E., Wang Y., Qin Z.H., Chen J.D., Nevins J.R., Aronin N., and DiFiglia M. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J. Biol. Chem. 277 (2002) 7466-7476
26. Kempermann G., and Gage F.H. Genetic influence on phenotypic differentiation in adult hippocampal neurogenesis. Brain Res. Dev. Brain. Res. 134 (2002) 1-12
27. Kempermann G., Gast D., and Gage F.H. Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann. Neurol. 52 (2002) 135-143
28. Kuhn A., Goldstein D.R., Hodges A., Strand A.D., Sengstag T., Kooperberg C., Becanovic K., Pouladi M.A., Sathasivam K., Cha J.H., Hannan A.J., Hayden M.R., Leavitt B.R., Dunnett S.B., Ferrante R.J., Albin R., Shelbourne P., Delorenzi M., Augood S.J., Faull R.L., Olson J.M., Bates G.P., Jones L., and Luthi-Carter R. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet. 16 (2007) 1845-1861
29. Lee M.K., and Cleveland D.W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19 (1996) 187-217
30. Li S.H., Cheng A.L., Zhou H., Lam S., Rao M., Li H., and Li X.J. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell Biol. 22 (2002) 1277-1287
31. Lin C.H., Tallaksen-Greene S., Chien W.M., Cearley J.A., Jackson W.S., Crouse A.B., Ren S., Li X.J., Albin R.L., and Detloff P.J. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 10 (2001) 137-144
32. Lorincz M.T. Optimized neuronal differentiation of murine embryonic stem cells: role of cell density. Methods Mol. Biol. 330 (2006) 55-69
33. Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., Frey A.S., Spektor B.S., Penney E.B., Schilling G., Ross C.A., Borchelt D.R., Tapscott S.J., Young A.B., Cha J.H., and Olson J.M. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9 (2000) 1259-1271
34. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., and Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
35. Menezes J.R., and Luskin M.B. Expression of neuron-specific tubulin defines a novel population in the proliferative layers of the developing telencephalon. J. Neurosci. 14 (1994) 5399-5416
36. Ming G.L., and Song H. Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 28 (2005) 223-250
37. Miyata T., Maeda T., and Lee J.E. NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev. 13 (1999) 1647-1652
38. Molyneaux B.J., Arlotta P., Menezes J.R., and Macklis J.D. Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8 (2007) 427-437
39. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., and Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
40. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., and Ross C.A. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
41. Parent J.M., Valentin V.V., and Lowenstein D.H. Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J. Neurosci. 22 (2002) 3174-3188
42. Parent J.M., Vexler Z.S., Gong C., Derugin N., and Ferriero D.M. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol. 52 (2002) 802-813
43. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5355-5358
44. Phillips W., Morton A.J., and Barker R.A. Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment. J. Neurosci. 25 (2005) 11564-11576
45. Puelles L., Kuwana E., Puelles E., Bulfone A., Shimamura K., Keleher J., Smiga S., and Rubenstein J.L. Pallial and subpallial derivatives in the embryonic chick and mouse telencephalon, traced by the expression of the genes Dlx-2, Emx-1, Nkx-2.1, Pax-6, and Tbr-1. J. Comp. Neurol. 424 (2000) 409-438
46. Quarles R.H., and Trapp B.D. Localization of myelin-associated glycoprotein. J. Neurochem. 43 (1984) 1773-1777
47. Rallu M., Corbin J.G., and Fishell G. Parsing the prosencephalon. Nat. Rev. Neurosci. 3 (2002) 943-951
48. Rietze R.L., and Reynolds B.A. Neural stem cell isolation and characterization. Methods Enzymol. 419 (2006) 3-23
49. Sakakibara S., Imai T., Hamaguchi K., Okabe M., Aruga J., Nakajima K., Yasutomi D., Nagata T., Kurihara Y., Uesugi S., Miyata T., Ogawa M., Mikoshiba K., and Okano H. Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev. Biol. 176 (1996) 230-242
50. Schauwecker P.E. Genetic influence on neurogenesis in the dentate gyrus of two strains of adult mice. Brain Res. 1120 (2006) 83-92
51. Shimeld S.M., Gaunt S.J., Coletta P.L., Geada A.M., and Sharpe P.T. Spatial localisation of transcripts of the Hox-C6 gene. J. Anat. 183 Pt 3 (1993) 515-523
52. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., and Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6763-6768
53. Stenman J., Toresson H., and Campbell K. Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. J. Neurosci. 23 (2003) 167-174
54. Sudhof T.C., Lottspeich F., Greengard P., Mehl E., and Jahn R. A synaptic vesicle protein with a novel cytoplasmic domain and four transmembrane regions. Science 238 (1987) 1142-1144
55. Sussel L., Marin O., Kimura S., and Rubenstein J.L. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development 126 (1999) 3359-3370
56. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 (1998) 369-384
57. Wang T.W., Stromberg G.P., Whitney J.T., Brower N.W., Klymkowsky M.W., and Parent J.M. Sox3 expression identifies neural progenitors in persistent neonatal and adult mouse forebrain germinative zones. J. Comp. Neurol. 497 (2006) 88-100
58. Ying Q.L., Stavridis M., Griffiths D., Li M., and Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21 (2003) 183-186
59. Zhou Q., Wang S., and Anderson D.J. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron. 25 (2000) 331-343
60. Zuccato C., Tartari M., Crotti A., Goffredo D., Valenza M., Conti L., Cataudella T., Leavitt B.R., Hayden M.R., Timmusk T., Rigamonti D., and Cattaneo E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35 (2003) 76-83